We are live on ! Find out more
Mariner

Mariner Portfolio holdings

AUM $85.7B
1-Year Est. Return 24.21%
This Fund
S&P 500
This Quarter Est. Return
+11.61%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$69.3B
AUM Growth
+$9.18B
Cap. Flow
+$3.47B
Cap. Flow %
5.01%
Top 10 Hldgs %
26.5%
Holding
3,740
New
311
Increased
1,893
Reduced
1,169
Closed
273

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$261M
2
MSFT icon
Microsoft
MSFT
+$169M
3
GEV icon
GE Vernova
GEV
+$143M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$107M
5
JPM icon
JPMorgan Chase
JPM
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 20.78%
2 Financials 8.14%
3 Consumer Discretionary 5.23%
4 Healthcare 4.75%
5 Communication Services 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRH icon
3201
Diamondrock Hospitality Co
DRH
$2.63B
$119K ﹤0.01%
+15,493
New +$116K
GERN icon
3202
Geron
GERN
$911M
$119K ﹤0.01%
84,140
+16,699
+25% +$23.7K
EDIT icon
3203
Editas Medicine
EDIT
$399M
$118K ﹤0.01%
53,740
+31,959
+147% +$52.3K
HPK icon
3204
HighPeak Energy
HPK
$967M
$118K ﹤0.01%
+12,049
New +$119K
MITK icon
3205
Mitek Systems
MITK
$762M
$118K ﹤0.01%
11,898
-7,307
-38% -$65.6K
HIO
3206
Western Asset High Income Opportunity Fund
HIO
$335M
$118K ﹤0.01%
29,580
+14,440
+95% +$55.5K
XIFR
3207
XPLR Infrastructure LP
XIFR
$1.18B
$117K ﹤0.01%
14,275
+3,900
+38% +$33.9K
KSS icon
3208
Kohl's
KSS
$2.03B
$117K ﹤0.01%
+13,769
New +$106K
UDMY
3209
DELISTED
Udemy
UDMY
$116K ﹤0.01%
16,530
-15,282
-48% -$105K
IRWD icon
3210
Ironwood Pharmaceuticals
IRWD
$611M
$116K ﹤0.01%
161,574
-588,426
-78% -$462K
DNUT icon
3211
Krispy Kreme
DNUT
$543M
$116K ﹤0.01%
39,807
+20,561
+107% +$71.8K
BCAX
3212
Bicara Therapeutics
BCAX
$1.78B
$116K ﹤0.01%
+12,437
New +$148K
CCLD icon
3213
CareCloud
CCLD
$94.3M
$115K ﹤0.01%
+48,841
New +$92.8K
RUM icon
3214
RUM Group Inc
RUM
$1.57B
$115K ﹤0.01%
12,769
-800
-6% -$6.84K
CMRE icon
3215
Costamare
CMRE
$1.9B
$115K ﹤0.01%
12,585
+1,741
+16% +$15.5K
DYN icon
3216
Dyne Therapeutics
DYN
$4.04B
$114K ﹤0.01%
11,953
-13,699
-53% -$151K
LEO
3217
BNY Mellon Strategic Municipals
LEO
$387M
$114K ﹤0.01%
19,203
+1,137
+6% +$6.65K
SGMT icon
3218
Sagimet Biosciences
SGMT
$437M
$114K ﹤0.01%
14,900
CIO
3219
DELISTED
City Office REIT
CIO
$113K ﹤0.01%
21,232
+9,118
+75% +$45.7K
NXE icon
3220
NexGen Energy
NXE
$6.05B
$113K ﹤0.01%
16,304
-1,066
-6% -$6.02K
ARRY icon
3221
Array Technologies
ARRY
$818M
$112K ﹤0.01%
19,003
+6,248
+49% +$37.9K
SLS icon
3222
SELLAS Life Sciences
SLS
$2.23B
$112K ﹤0.01%
51,109
-91
-0.2% -$140
RCS
3223
PIMCO Strategic Income Fund
RCS
$243M
$112K ﹤0.01%
+16,063
New +$99.7K
PANL icon
3224
Pangaea Logistics
PANL
$501M
$111K ﹤0.01%
23,693
-1,860
-7% -$8.26K
GUT
3225
Gabelli Utility Trust
GUT
$576M
$111K ﹤0.01%
19,174
+367
+2% +$1.99K

Similar funds

Mariner's Q2 2025 Portfolio in Review

As of Q2 2025, Mariner held 3,740 positions worth $69.3B, up 15% from $60.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Mariner deployed $3.47B of net new capital in Q2 2025, opening 311 new positions and adding to 1,893 existing holdings. Its largest new stake was iShares MSCI USA Small-Cap Min Vol Factor ETF: 384,640 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Union Pacific, an estimated $83.9M trimmed.

  • Mariner's largest Q2 2025 buy was iShares MSCI USA Small-Cap Min Vol Factor ETF: 384,640 shares worth $16.2M.
  • Mariner added most to Apple in Q2 2025, an estimated $261M increase.
  • Mariner's biggest Q2 2025 reduction was Union Pacific, cutting an estimated $83.9M.
  • Mariner fully exited Discover Financial Services in Q2 2025, selling an estimated $7.86M.
  • Mariner's ten largest holdings make up 26% of its $69.3B portfolio in Q2 2025.
  • Mariner opened 311 new positions and closed 273 in Q2 2025.
  • Mariner's portfolio value rose 15% quarter-over-quarter to $69.3B.

Based on Mariner's 13F filing for Q2 2025, filed 14 Aug 2025.